BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Society of Cannabis Clinicians - ECPv6.15.15//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.cannabisclinicians.org
X-WR-CALDESC:Events for Society of Cannabis Clinicians
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210702T090000
DTEND;TZID=America/Los_Angeles:20210702T100000
DTSTAMP:20260624T180729
CREATED:20201120T170946Z
LAST-MODIFIED:20210616T090325Z
UID:10000063-1625216400-1625220000@www.cannabisclinicians.org
SUMMARY:Monthly Journal Club: James Lowder\, MD & Patrick Tso\, PhD on Pharmacokinetics of Cannabinoids & the Lipid Absorption Pathway
DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nPresenters:\nJames Lowder\, MD & Patrick Tso\, PhD (bios below) \nTopic:\nPharmacokinetics of Cannabinoids & the Lipid Absorption Pathway \nArticles to be Discussed:\n\nHuman Metabolites of Cannabidiol: A Review on Their Formation\, Biological Activity\, and Relevance in Therapy\nThe Pharmacokinetics and the Pharmacodynamics of Cannabinoids\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nJames N. Lowder\, MD is a board-certified oncologist trained at Case Western Reserve University and Stanford University\, formerly on the staff of the Cleveland Clinic. He has worked in development in the pharmaceutical and diagnostic industry for 30 years and is currently the Chief Medical Officer at Impact-Naturals\, a company developing cannabinoid products for use\nin the enhancement of life-style and personal health. Impact-Naturals aims to produce products which are designed using scientific principles throughout their journey from inception to the hands of the customer. \n  \nPatrick Tso\, PhD graduated in 1978 from the University of Western Australia in Physiology working under Professor W.J. Simmonds. His thesis work was on the role of biliary lecithin on the formation and secretion of chylomicrons. He has worked extensively with the gastrointestinal tract and the lymphatic system (over 40 years)\, especially the absorption of lipids. He has published at length on the formation and secretion of chylomicrons and the process regulating it. He was awarded the Distinguished Research prize from the American Physiological Society for his work on apolipoprotein A-IV. Over the years\, his laboratory has pioneered a number of concepts and approaches to study intestinal fat absorption. He has over 20 years on various NIH Study Sections and 4 years on the NIDDK Council\, and has consulted with a number of pharmaceutical companies including: Ajinomoto of Japan\, Lilly\, Johnson and Johnson\, Pfizer\, Upjohn\, Catalent\, Abbott Nutrition\, Merck\, Sankyo. He is currently the Mary Emery Professor of Pathology.
URL:https://www.cannabisclinicians.org/event/monthly-journal-club-july/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210711T100000
DTEND;TZID=America/Los_Angeles:20210711T120000
DTSTAMP:20260624T180729
CREATED:20210621T062606Z
LAST-MODIFIED:20210624T090550Z
UID:10000086-1625997600-1626004800@www.cannabisclinicians.org
SUMMARY:Quarterly Meeting: Emerging Indications for Medical Cannabis in Older Adults with Addie Ron\, MD
DESCRIPTION:Join us for our quarterly meeting\, available to all SCC members. Addie Ron\, MD is the featured speaker who will be exploring: Emerging Indications for Medical Cannabis in Older Adults. \nDr. Ron will talk about the major indications for medical cannabis in older adults and share some of his  published and unpublished data\, including real life stories from his practice. Read more about Dr. Ron in the bio below. \nThe meeting is remote and free to all SCC members. Non members can also join for $10. Members can log in to the membership portal for instructions on how to join. \n  \nRSVP >> \n  \n \nAddie Ron\, MD is an Israeli physician certified in Geriatrics and Family Medicine. He holds a Master’s degree in Gerontology from Haifa University and completed a Geriatrics fellowship program at Boston University Medical Center. Doctor Ron is a practicing clinician for the last 20 years working at Maccabi Health Services\, the second largest HMO in Israel. In 2017 he entered the cannabis field as well by joining Niamedic as the Medical Director. NiaMedic is a medical data company offering healthcare\, research & consultation services in the cannabis field. As a Geriatrician Doctor Ron focused on treating older adults with Medical Cannabis while collecting data and following hundreds of patients. He recently published with his colleagues a summary article: Medical Cannabis for Older Patients Treatment Protocol and Initial Results (J Clin Med 2019 Nov 1; 8(11):1819.). Doctor Ron continues his practice and research in treating older adults with medical cannabis and is now cooperating with Tikun Olam on summarizing the effect of medical cannabis in reducing polypharmacy.
URL:https://www.cannabisclinicians.org/event/quarterly-meeting-emerging-indications-for-medical-cannabis-in-older-adults-with-addie-ron-md/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/06/Quarterly-Meeting-website-banner.jpg
ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210722T090000
DTEND;TZID=America/Los_Angeles:20210722T100000
DTSTAMP:20260624T180729
CREATED:20210526T130228Z
LAST-MODIFIED:20210526T130228Z
UID:10000083-1626944400-1626948000@www.cannabisclinicians.org
SUMMARY:Canna Talk with Frye & Wilson-King: Ethan Russo\, MD & Endocannabinoid Deficiency
DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the July edition of “Canna Talk with Frye and Wilson-King” on July 22nd as we explore Clinical Endocannabinoid Deficiency with Ethan Russo\, MD\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Russo and discuss his line of research on the topic of Clinical Endocannabinoid Deficiency and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Russo presented in the SCC Clinical Training Module Clinical Endocannabinoid Deficiency. Learn more about Dr. Russo in the bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nEthan Russo\, MD is a board-certified neurologist\, psychopharmacology researcher\, and author. He is the Founder and CEO of Credo Science. \nPreviously\, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague\, Czech Republic. Medical Director of PHYTECS (2015-2017)\, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system\, and from 2003-2014\, he served as Senior Medical Advisor\, medical monitor and study physician to GW Pharmaceuticals\, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy. \nHe graduated from the University of Pennsylvania (Psychology)\, and the University of Massachusetts Medical School\, before residencies in Pediatrics in Phoenix\, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula\, Montana for 20 years in a practice with a strong chronic pain component. In 1995\, he pursued a 3-month sabbatical doing ethnobotanical research with the Machiguenga people in Parque Nacional del Manu\, Peru. \nHe has held faculty appointments in Pharmaceutical Sciences at the University of Montana\, in Medicine at the University of Washington\, and as visiting professor\, Chinese Academy of Sciences\, Harvard University\, and Johns Hopkins University. \nHe is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs\, co-editor of Cannabis and Cannabinoids: Pharmacology\, Toxicology and Therapeutic Potential\, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics\, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS\, Women and Cannabis: Medicine\, Science and Sociology\, Cannabis: From Pariah to Prescription\, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He has also published numerous book chapters\, and over fifty articles in neurology\, pain management\, cannabis\, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms\, phytopharmaceutical treatment of migraine and chronic pain\, herbal synergy and phytocannabinoid/terpenoid\, serotonergic and vanilloid interactions. \nHe has consulted or lectured on these topics in 44 US states and Canadian provinces and 44 countries on six continents.
URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-ethan-russo-md-endocannabinoid-deficiency/
LOCATION:Zoom
ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg
END:VEVENT
END:VCALENDAR